Coya Therapeutics, Inc. (COYA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
COYA currently has 22.6M outstanding shares. with significant dilution risk as 18.9M authorized shares could dilute existing holders by 83.3%. The company has significantly diluted shareholders by 51.2% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 12, 2026 |
10-Q filing | 22.6M shares outstanding |
23M | 19M |
| Mar 16, 2026 |
10-K filing | 23.5M shares outstanding |
23M | 19M |
| Nov 12, 2025 |
10-Q filing | 20.9M shares outstanding |
21M | 19M |
| Aug 12, 2025 |
S-3 filing: Coya Therapeutics, Inc. files an S-3 registration statement to offer and sell up to $75,000,000 of common stock, preferred stock, debt securities, subscription rights and units. |
17M | 19M |
| Aug 12, 2025 |
10-Q filing | 16.7M shares outstanding |
17M | 6.7M |
| May 13, 2025 |
10-Q filing | 16.7M shares outstanding |
17M | 6.7M |
| Mar 18, 2025 |
10-K filing | 15.2M shares outstanding |
15M | 6.7M |
| Nov 20, 2024 |
S-3 filing: This prospectus relates to the resale of up to 1,379,314 shares of Coya Therapeutics, Inc. common stock by the selling stockholders. |
15M | 6.7M |
| Nov 06, 2024 |
10-Q filing | 15.2M shares outstanding |
15M | 5.3M |
| Aug 12, 2024 |
10-Q filing | 14.9M shares outstanding |
15M | 5.3M |
| Jun 14, 2024 |
S-3 filing: This prospectus relates to the resale of up to 603,136 shares of Coya Therapeutics, Inc. common stock, by the selling stockholder listed in this prospectus or its permitted transferees. |
15M | 5.3M |
| May 09, 2024 |
10-Q filing | 14.5M shares outstanding |
14M | 4.7M |
| Mar 19, 2024 |
10-K filing | 14.5M shares outstanding |
15M | 4.7M |
| Jan 04, 2024 |
S-3 filing: This prospectus relates to the resale of up to 4,689,386 shares of Coya Therapeutics, Inc. common stock by the selling stockholders. |
10M | 4.7M |
| Nov 08, 2023 |
10-Q filing | 9.9M shares outstanding |
9.9M | 0 |
| Aug 08, 2023 |
10-Q filing | 9.9M shares outstanding |
9.9M | 0 |
| May 10, 2023 |
10-Q filing | 9.7M shares outstanding |
9.7M | 0 |
| May 08, 2023 |
POS AM filing: This is a POS AM filing for Coya Therapeutics, Inc. relating to the offer and sale of up to 1,670,000 shares of common stock underlying warrants previously issued in their IPO, with an exercise price of $7.50 per share, expiring on January 3, 2025. |
9.9M | 0 |
| Mar 29, 2023 |
10-K filing | 9.9M shares outstanding |
9.9M | 4.6M |
| Jan 25, 2023 |
8-K filing: Coya Therapeutics, Inc. sold an additional 237,804 shares of common stock and accompanying warrants upon the underwriters' exercise of their over-allotment option, completing the initial public offering for total gross proceeds of approximately $16.4 million. |
9.7M | 4.6M |
| Dec 13, 2022 |
S-1/A filing: This is the initial public offering of shares of common stock and warrants to purchase shares of common stock of Coya Therapeutics, Inc. |
9.7M | 4.6M |
| Dec 05, 2022 |
S-1/A filing: This is the initial public offering of shares of common stock and warrants to purchase shares of common stock of Coya Therapeutics, Inc. |
9.7M | 4.8M |
| Nov 18, 2022 |
S-1 filing: This is the initial public offering of shares of common stock of Coya Therapeutics, Inc. |
N/A | 0 |